TY  - JOUR
AU  - Drosten, Matthias
AU  - Barbacid, Mariano
PY  - 2022
DO  - 10.1002/1878-0261.13341
UR  - http://hdl.handle.net/20.500.12105/18964
AB  - KRASG12D is the most frequent KRAS mutation in human cancer with particularly high frequencies in pancreatic and colorectal cancer. Informed by the structure of the KRASG12C inhibitor adagrasib, Hallin et al. have now, through multiple rounds of...
LA  - eng
PB  - Wiley
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Colorectal Neoplasms
KW  - Humans
KW  - Mutation
KW  - Piperazines
TI  - KRAS inhibitors: going noncovalent.
TY  - journal article
ER  -